STOCK TITAN

Thermo Fisher COO Pettiti sells shares at $701.42

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Thermo Fisher Scientific Inc. (TMO) President & COO Gianluca Pettiti exercised options for 3,733 common shares at $309.63 per share on November 13, 2026. Pettiti also sold 3,733 common shares and 400 common shares, each sale at $701.42 per share. The transactions were made under a Rule 10b5-1 trading plan adopted June 2, 2026. The option vested in four equal installments on February 25, 2021, February 25, 2022, February 25, 2023 and February 25, 2024.

Insider Pettiti Gianluca
Role President & COO
Sold 4,133 shs ($2.90M)
Approx. gross sale proceeds $2.90M
Approx. exercise cost $1.16M
Share of Position Sold 15.3%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F2 3,733 $0.00 $0.00
Sale Common Stock F1 400 $701.42 $281K
Exercise Common Stock 3,733 $309.63 $1.16M
Sale Common Stock F1 3,733 $701.42 $2.62M
Holdings After Transaction: Stock Option (Right to Buy) — 3,734 options (Direct); Common Stock — 22,816.14 shares (Direct)
Holdings Before and After: Stock Option (Right to Buy), 7,467 to 3,734 options (Direct); Common Stock, 23,216.14 to 22,816.14 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
  1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.
  2. F2. The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024.
Common shares sold 3,733 shares at $701.42 per share Sale reported for November 13, 2026
Common shares sold 400 shares at $701.42 per share Separate sale reported for November 13, 2026
Options exercised 3,733 options for 3,733 common shares Exercise reported for November 13, 2026
Exercise price $309.63 per share Options exercised on November 13, 2026
Options following exercise 3,734 shares Reported direct position following the November 13, 2026 transaction
Rule 10b5-1 trading plan financial
"transactions were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
vested in four equal installments financial
"The option vested in four equal installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TMO shares did President & COO Gianluca Pettiti sell, and at what price?

On November 13, 2026, Gianluca Pettiti sold 3,733 common shares at $701.42 per share and separately sold 400 common shares at $701.42 per share. The transactions were made under a Rule 10b5-1 trading plan adopted June 2, 2026.

What options did TMO President & COO Gianluca Pettiti exercise?

On November 13, 2026, Gianluca Pettiti exercised options for 3,733 common shares at an exercise price of $309.63 per share. The option vested in four equal installments on February 25, 2021, February 25, 2022, February 25, 2023 and February 25, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pettiti Gianluca

(Last)(First)(Middle)
168 THIRD AVENUE

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President & COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/13/2026S(1)400D$701.4222,816.14D
Common Stock11/13/2026M3,733A$309.6326,549.14D
Common Stock11/13/2026S(1)3,733D$701.4222,816.14D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$309.6311/13/2026M3,733 (2)02/25/2027Common Stock3,733$03,734D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.
2. The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024.
Remarks:
/s/ Melodie T. Morin, Attorney-in-Fact for Gianluca Pettiti11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading